Author:
Gleason Mary Margaret,Goldson Edward,Yogman Michael W.,Lieser Dina,DelConte Beth,Donoghue Elaine,Earls Marian,Glassy Danette,McFadden Terri,Mendelsohn Alan,Scholer Seth,Takagishi Jennifer,Vanderbilt Douglas,Williams Patricia Gail,Yogman Michael,Bauer Nerissa,Gambon Thresia B,Lavin Arthur,Lemmon Keith M.,Mattson Gerri,Rafferty Jason Richard,Wissow Lawrence Sagin,Weitzman Carol Cohen,Bauer Nerissa S.,Childers David Omer,Levine Jack M.,Peralta-Carcelen Ada Myriam,Smith Peter Joseph,Blum Nathan J.,Contompasis Stephen H.,Korb Damon Russell,McGuinn Laura Joan,Voigt Robert G., , ,
Abstract
More than 10% of young children experience clinically significant mental health problems, with rates of impairment and persistence comparable to those seen in older children. For many of these clinical disorders, effective treatments supported by rigorous data are available. On the other hand, rigorous support for psychopharmacologic interventions is limited to 2 large randomized controlled trials. Access to psychotherapeutic interventions is limited. The pediatrician has a critical role as the leader of the medical home to promote well-being that includes emotional, behavioral, and relationship health. To be effective in this role, pediatricians promote the use of safe and effective treatments and recognize the limitations of psychopharmacologic interventions. This technical report reviews the data supporting treatments for young children with emotional, behavioral, and relationship problems and supports the policy statement of the same name.
Publisher
American Academy of Pediatrics (AAP)
Subject
Pediatrics, Perinatology, and Child Health